Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins

After autoimmune inflammation, interactions between CD95 and its ligand (CD95L) mediate thyrocyte destruction in Hashimoto's thyroiditis (HT). Conversely, thyroid autoimmune processes that lead to Graves' disease (GD) result in autoantibody-mediated thyrotropin receptor stimulation without thyrocyte depletion. We found that GD thyrocytes expressed CD95 and CD95L in a similar manner to HT thyrocytes, but did not undergo CD95-induced apoptosis either in vivo or in vitro. This pattern was due to the differential production of TH1 and TH2 cytokines. Interferon γ promoted caspase up-regulation and CD95-induced apoptosis in HT thyrocytes, whereas interleukin 4 and interleukin 10 protected GD thyrocytes by potent up-regulation of cFLIP and Bcl-xL, which prevented CD95-induced apoptosis in sensitized thyrocytes. Thus, modulation of apoptosis-related proteins by TH1 and TH2 cytokines controls thyrocyte survival in thyroid autoimmunity.

[1]  M. Todaro,et al.  Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. , 1999, Journal of immunology.

[2]  N. Mitsiades,et al.  Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. , 1998, The Journal of clinical endocrinology and metabolism.

[3]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[4]  M. Hayden,et al.  Cell death attenuation by `Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex , 1998, Cell Death and Differentiation.

[5]  V. Kuchroo,et al.  Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. , 1997, Journal of immunology.

[6]  K. Koretz,et al.  Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[7]  S. Srinivasula,et al.  Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 , 1999, Nature.

[8]  S. Stohlman,et al.  Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: Relative roles of interleukin (IL)-4 and IL-10 , 1993, Journal of Neuroimmunology.

[9]  E. Shevach,et al.  Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. , 1994 .

[10]  P. Krammer.  CD95(APO-1/Fas)-mediated apoptosis: live and let die. , 1999, Advances in immunology.

[11]  N. Sarvetnick,et al.  Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ , 1990, Nature.

[12]  M. Todaro,et al.  Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis , 1997, Science.

[13]  R. Mirakian,et al.  ANALYSIS OF APOPTOSIS IN RELATION TO TISSUE DESTRUCTION ASSOCIATED WITH HASHIMOTO'S AUTOIMMUNE THYROIDITIS , 1997, The Journal of pathology.

[14]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[15]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[16]  Y. Lévy,et al.  Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. , 1994, The Journal of clinical investigation.

[17]  N. Sarvetnick,et al.  Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. , 1999, Journal of immunology.

[18]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[19]  A. Cross,et al.  Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. , 1997, Journal of immunology.

[20]  S. Nagataki,et al.  Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. , 1996, Endocrinology.

[21]  R. Naphthine.  Live and let die. , 1994, Australian nursing journal.

[22]  P. Ladenson,et al.  IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease , 1994, Clinical and experimental immunology.

[23]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[24]  B. Mignotte,et al.  Mitochondria and apoptosis. , 1998, European journal of biochemistry.

[25]  G P Nolan,et al.  High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. , 1998, Cancer research.

[26]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[27]  R. Maria,et al.  Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. , 1998, Immunology today.

[28]  F. Matsuzuka,et al.  Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8- cells, in autoimmune thyroid disease. , 1993, Clinical and experimental immunology.

[29]  G. Daniels,et al.  Chronic autoimmune thyroiditis. , 1996, The New England journal of medicine.

[30]  D. Hinton,et al.  Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10. , 1999, Journal of immunology.

[31]  Ingo Schmitz,et al.  The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[32]  M. Feldmann,et al.  HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin , 1987, Nature.

[33]  S. Srinivasula,et al.  FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[34]  A. Weetman,et al.  Autoimmune thyroid disease: further developments in our understanding. , 1994, Endocrine reviews.

[35]  M. Sospedra,et al.  Single‐cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease , 1997, European journal of immunology.

[36]  J. Buer,et al.  Interleukin 10 Secretion and Impaired Effector Function of Major Histocompatibility Complex Class II–restricted T Cells Anergized In Vivo , 1998, The Journal of experimental medicine.

[37]  H. Simon,et al.  Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. , 1998, Blood.

[38]  James R. Baker,et al.  Inflammatory Cytokine Regulation of Fas-mediated Apoptosis in Thyroid Follicular Cells* , 1999, The Journal of Biological Chemistry.